The Role of MUC1 in Renal Cell Carcinoma

Martina Milella(University of Bari Aldo Moro), Giuseppe Lucarelli(University of Bari Aldo Moro), Francesco Lasorsa(University of Bari Aldo Moro), Michele Battaglia(University of Bari Aldo Moro), Marco Spilotros(University of Bari Aldo Moro), Pasquale Ditonno(University of Bari Aldo Moro), Felice Crocetto(University of Naples Federico II), Monica Rutigliano(University of Bari Aldo Moro), Giuseppe Fallara(Istituti di Ricovero e Cura a Carattere Scientifico), Savio Domenico Pandolfo(University of L'Aquila), Antonio d’Amati(University of Bari Aldo Moro), Biagio Barone(University of Naples Federico II), Roberto Bianchi(Istituti di Ricovero e Cura a Carattere Scientifico), Matteo Ferro(European Institute of Oncology)
Biomolecules
March 7, 2024
10.3390/biom14030315
Cited by 59

Related Papers

Integrated multi-omics characterization reveals a distinctive metabolic signature and the role of NDUFA4L2 in promoting angiogenesis, chemoresistance, and mitochondrial dysfunction in clear cell renal cell carcinoma
|Aging|2018|247
Renal Cell Carcinoma as a Metabolic Disease: An Update on Main Pathways, Potential Biomarkers, and Therapeutic Targets
|International Journal of Molecular Sciences|2022|190
Immune Checkpoint Inhibitors in Renal Cell Carcinoma: Molecular Basis and Rationale for Their Use in Clinical Practice
|Biomedicines|2023|161
Association of NAFLD and Insulin Resistance with Non Metastatic Bladder Cancer Patients: A Cross-Sectional Retrospective Study
|Journal of Clinical Medicine|2021|131
Cellular and Molecular Players in the Tumor Microenvironment of Renal Cell Carcinoma
|Journal of Clinical Medicine|2023|129